The FDA has accepted for filing Actavis' supplemental New Drug Application (sNDA) to expand the label for Teflaro (ceftaroline fosamil)...
Actavis plc announced that it will adopt a new corporate name - Allergan - following the anticipated successful completion of...
Actavis plc announced that it has launched its generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) 0.25 and 0.5...
Actavis plc and Gedeon Richter Plc have announced that the FDA has acknowledged receipt of Actavis' New Drug Application (NDA)...
Vivus Inc has announced that Actavis Plc plans to market a generic version of Qsymia (phentermine plus topiramate).Actavis has already...
Actavis plc , a leading global specialty pharmaceutical company, and Durata Therapeutics, Inc. , an innovative pharmaceutical company focused on...
Actavis plc announced that the company has adopted Allergan plc as its new global name and will begin trading today...
Actavis and Medicines360 have announced the approval of Liletta (levonorgestrel-releasing intrauterine system) by the FDA for use by women to...
Celgene Corporation has announced it has received a Paragraph IV Notice Letter advising that Actavis LLC submitted an Abbreviated New...
Actavis plc has confirmed that the FDA Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against approval...